Hemophilia Stocks List

Recent Signals

Date Stock Signal Type
2020-02-14 ALNY NR7 Range Contraction
2020-02-14 ALNY Upper Bollinger Band Walk Strength
2020-02-14 BAX Upper Bollinger Band Walk Strength
2020-02-14 BIIB Narrow Range Bar Range Contraction
2020-02-14 BIIB Spinning Top Other
2020-02-14 BIIB 1,2,3 Pullback Bullish Bullish Swing Setup
2020-02-14 BIIB Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-02-14 BIIB NR7 Range Contraction
2020-02-14 CBIO Calm After Storm Range Contraction
2020-02-14 CBIO NR7 Range Contraction
2020-02-14 CBIO Narrow Range Bar Range Contraction
2020-02-14 GRFS Pocket Pivot Bullish Swing Setup
2020-02-14 MGLN Bearish Engulfing Bearish
2020-02-14 MGLN Fell Below 20 DMA Bearish
2020-02-14 PFE Stochastic Reached Oversold Weakness
2020-02-14 PFE Cup with Handle Other

Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. This results in people bleeding longer after an injury, easy bruising, and an increased risk of bleeding inside joints or the brain. Those with a mild case of the disease may have symptoms only after an accident or during surgery. Bleeding into a joint can result in permanent damage while bleeding in the brain can result in long term headaches, seizures, or a decreased level of consciousness.There are two main types of haemophilia: haemophilia A, which occurs due to not enough clotting factor VIII, and haemophilia B, which occurs due to not enough clotting factor IX. They are typically inherited from one's parents through an X chromosome with a nonfunctional gene. Rarely a new mutation may occur during early development or haemophilia may develop later in life due to antibodies forming against a clotting factor. Other types include haemophilia C, which occurs due to not enough factor XI, and parahaemophilia, which occurs due to not enough factor V. Acquired haemophilia is associated with cancers, autoimmune disorders, and pregnancy. Diagnosis is by testing the blood for its ability to clot and its levels of clotting factors.Prevention may occur by removing an egg, fertilizing it, and testing the embryo before transferring it to the uterus. Treatment is by replacing the missing blood clotting factors. This may be done on a regular basis or during bleeding episodes. Replacement may take place at home or in hospital. The clotting factors are made either from human blood or by recombinant methods. Up to 20% of people develop antibodies to the clotting factors which makes treatment more difficult. The medication desmopressin may be used in those with mild haemophilia A. Studies of gene therapy are in early human trials.Haemophilia A affects about 1 in 5,000–10,000, while haemophilia B affects about 1 in 40,000, males at birth. As haemophilia A and B are both X-linked recessive disorders, females are rarely severely affected. Some females with a nonfunctional gene on one of the X chromosomes may be mildly symptomatic. Haemophilia C occurs equally in both sexes and is mostly found in Ashkenazi Jews. In the 1800s haemophilia was common within the royal families of Europe. The difference between haemophilia A and B was determined in 1952. The word is from the Greek haima αἷμα meaning blood and philia φιλία meaning love.

More about Hemophilia